Thyrotoxic periodic paralysis: A review

Journal of Intensive Care Medicine

Volumn 25, Issue 2, 2010, Pages 71-77

  Pothiwala, Pooja ^a   Levine, Steven N ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Hyperthyroidism; Hypokalemia; Hypokalemic periodic paralysis; Paralysis; Thyrotoxicosis

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEVOTHYROXINE; LIOTHYRONINE; POTASSIUM CHLORIDE; PROPRANOLOL; RADIOACTIVE IODINE; SPIRONOLACTONE; THIAMAZOLE; THYROXINE; ANTITHYROID AGENT; POTASSIUM;

AORTA STENOSIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GRAVES DISEASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERKALEMIA; HYPERTHYROIDISM; HYPOKALEMIA; HYPOTHYROIDISM; LABORATORY TEST; MORBIDITY; MUSCLE WEAKNESS; PARALYSIS; PATHOGENESIS; PERIODIC PARALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; THYROID CRISIS; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTOXIC PERIODIC PARALYSIS; THYROTOXICOSIS; FEMALE; MALE; SEX DIFFERENCE;

ADRENERGIC BETA-ANTAGONISTS; ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAVES DISEASE; HUMANS; HYPOKALEMIA; MALE; PARALYSIS; POTASSIUM; SEX FACTORS; THYROTOXICOSIS;

EID: 77950212878     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066609358849     Document Type: Review

References (55)

1. Lin SH Thyrotoxic periodic paralysis. Mayo Clin Proc. 2005 ; 80 (1). 99-105.
2. Ozaki H., Mori K., Nakagawa Y., Hoshikawa S., Ito S., Yoshida K. Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis. Endocr J. 2008 ; 55 (1). 113-119.
3. Alings AM, Fliers E., de Herder WW, et al. A thyrotropinsecreting pituitary adenoma as a cause of thyrotoxic periodic paralysis. J Endocrinol Invest. 1998 ; 21 (10). 703-706.
4. Peiris AN Thyrotoxic periodic paralysis. South Med J. 2002 ; 95 (11). 1233-1234.
5. Chen YC, Fang JT, Chang CT, Chou HH Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail. 2001 ; 23 (1). 139-142.
6. Dunlap H., Kepler K. A syndrome resembling familial periodic paralysis occurring in the course of exophthalmic goiter. Endocrinology. 1931 ; 15 (6). 541-546.
7. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J. 1967 ; 1 (5538). 451-455.
8. Okinaka S., Shizume K., Iino S., et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957 ; 17 (12). 1454-1459.
9. Elston MS, Orr-Walker BJ, Dissanayake AM, Conaglen JV Thyrotoxic, hypokalaemic periodic paralysis: polynesians, an ethnic group at risk. Intern Med J. 2007 ; 37 (5). 303-307.
10. Kelley DE, Gharib H., Kennedy FP, Duda RJ Jr, McManis PG Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989 ; 149 (11). 2597-2600.
11. Kilpatrick RE, Seiler-Smith S., Levine SN Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males. Thyroid. 1994 ; 4 (4). 441-445.
12. Magsino CH Jr, Ryan AJ Jr. Thyrotoxic periodic paralysis. South Med J. 2000 ; 93 (10). 996-1003.
13. Nellen H., Mercado M., Mendoza V., et al. Thyrotoxic periodic paralysis in Mexican mestizo patients: a clinical, biochemical and HLA-serological study. Arch Med Res. 1999 ; 30 (1). 74-76.
14. Tassone H., Moulin A., Henderson SO The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med. 2004 ; 26 (2). 157-161.
15. Conway MJ, Seibel JA, Eaton P. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med. 1974 ; 81 (3). 332-336.
16. Woolery WA, Gharib H. Thyrotoxic hypokalemic periodic paralysis in a white man. South Med J. 1991 ; 84 (11). 1399-1401.
17. Rone JK, Brietzke SA Euthyroid thyrotoxic periodic paralysis. Mil Med. 1991 ; 156 (8). 434-436.
18. Ober KP Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore). 1992 ; 71 (3). 109-120.
19. Lin MH, Akera T. Increased (Na+, K+)-ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J Biol Chem. 1978 ; 253 (3). 723-726.
20. Chan A., Shinde R., Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ. 1991 ; 303 (6810). 1096-1099.
21. Brown MJ, Brown DC, Murphy MB Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983 ; 309 (23). 1414-1419.
22. Gennari FJ Hypokalemia. N Engl J Med. 1998 ; 339 (7). 451-458.
23. Ginsberg AM, Clutter WE, Shah SD, Cryer PE Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest. 1981 ; 67 (6). 1785-1791.
24. Chan A., Shinde R., Chow CC, Cockram CS, Swaminathan R. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol (Oxf). 1994 ; 41 (2). 213-216.
25. Soonthornpun S., Setasuban W., Thamprasit A. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis. Clin Endocrinol (Oxf). 2009 ; 70 (5). 794-797.
26. Sejersted OM, Sjogaard G. Dynamics and consequences of potassium shifts in skeletal muscle and heart during exercise. Physiol Rev. 2000 ; 80 (4). 1411-1481.
27. Guerra M., Rodriguez del Castillo A., Battaner E., Mas M. Androgens stimulate preoptic area Na+, K+-ATPase activity in male rats. Neurosci Lett. 1987 ; 78 (1). 97-100.
28. Biering H., Bauditz J., Pirlich M., Lochs H., Gerl H. Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia. Horm Res. 2003 ; 59 (6). 301-304.
29. Tamai H., Tanaka K., Komaki G., et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab. 1987 ; 64 (5). 1075-1078.
30. Yeo PP, Chan SH, Lui KF, Wee GB, Lim P., Cheah JS HLA and thyrotoxic periodic paralysis. Br Med J. 1978 ; 2 (6142). 930.
31. Cesur M., Bayram F., Temel MA, et al. Thyrotoxic hypokalaemic periodic paralysis in a Turkish population: three new case reports and analysis of the case series. Clin Endocrinol (Oxf). 2008 ; 68 (1). 143-152.
32. Au KS, Yeung RT Thyrotoxic periodic paralysis. Periodic variation in the muscle calcium pump activity. Arch Neurol. 1972 ; 26 (6). 543-546.
33. Dunkle LM, Diggs CH, Bergman RA, Johns RJ A light and electron microscopic study of a second case of hypokalemic periodic paralysis with hyperthyroidism. Johns Hopkins Med J. 1970 ; 126 (6). 225-236.
34. Takeda R., Morimoto S., Uchida K., Miyamori I. Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysis. Acta Endocrinol (Copenh). 1976 ; 82 (4). 715-727.
35. Jongjaroenprasert W., Chanprasertyotin S., Butadej S., et al. Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population. Clin Endocrinol (Oxf). 2008 ; 68 (4). 646-651.
36. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab. 2002 ; 87 (11). 4881-4884.
37. Tang NL, Chow CC, Ko GT, et al. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients. Clin Endocrinol (Oxf). 2004 ; 61 (1). 109-112.
38. Kung AW, Lau KS, Fong GC, Chan V. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab. 2004 ; 89 (3). 1340-1345.
39. Gentric A., Le Deun P. Acute colonic pseudoobstruction: an unusual presentation of thyrotoxic periodic paralysis. J Am Geriatr Soc. 2005 ; 53 (12). 2237-2238.
40. Liu YC, Tsai WS, Chau T., Lin SH Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci. 2004 ; 327 (5). 264-267.
41. Boccalandro C., Lopez L., Boccalandro F., Lavis V. Electrocardiographic changes in thyrotoxic periodic paralysis. Am J Cardiol. 2003 ; 91 (6). 775-777.
42. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med. 1982 ; 142 (7). 1362-1364.
43. Hsieh MJ, Lyu RK, Chang WN, et al. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur J Neurol. 2008 ; 15 (6). 559-564.
44. Yang WS, Chu PL, Liu CH, Chung GB, Wu KD Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C. J Clin Gastroenterol. 2008 ; 42 (1). 112-113.
45. Wongraoprasert S., Buranasupkajorn P., Sridama V., Snabboon T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med. 2007 ; 46 (17). 1431-1433.
46. Brown JD, Kangwanprasert M., Tice A., Melish J. Thyrotoxic periodic paralysis in a Polynesian male following highly active anti-retroviral therapy for HIV infection. Hawaii Med J. 2007 ; 66 (3). 60, 62-63.
47. Donovan L., Parkins VM, Mahalingham A. Thyrotoxic periodic paralysis in pregnancy with impaired glucose tolerance: a case report and discussion of management issues. Thyroid. 2007 ; 17 (6). 579-583.
48. Lin SH, Lin YF, Chen DT, Chu P., Hsu CW, Halperin ML Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med. 2004 ; 164 (14). 1561-1566.
49. Kung AW Clinical review: thyrotoxic periodic paralysis: A diagnostic challenge. J Clin Endocrinol Metab. 2006 ; 91 (7). 2490-2495.
50. Lin SH, Chu P., Cheng CJ, Chu SJ, Hung YJ, Lin YF Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Crit Care Med. 2006 ; 34 (12). 2984-2989.
51. Shulkin D., Olson BR, Levey GS Thyrotoxic periodic paralysis in a Latin-American taking acetazolamide. Am J Med Sci. 1989 ; 297 (5). 337-338.
52. Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med. 2004 ; 22 (7). 544-547.
53. Manoukian MA, Foote JA, Crapo LM Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999 ; 159 (6). 601-606.
54. Shayne P., Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med. 1994 ; 24 (4). 736-740.
55. Lin SH, Lin YF Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001 ; 37 (3). 620-623.